Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Phosphatidylserine index as a marker of the procoagulant phenotype of acute myelogenous leukemia cells.

Physical biology - 1 Oct 2013

Tormoen Garth W, Recht Olivia, Gruber András, Levine Ross L, McCarty Owen J T

Abstract excerpt

Patients with acute myelogenous leukemia (AML) are at risk for thrombotic complications. Risk to develop thrombosis is closely tied to leukemia subtype, and studies have shown an association between leukocytosis and thrombosis in AML M3. We evaluated the relative roles of cell count and the surface expression of tissue factor (TF) and phosphatidylserine (PS) in the procoagulant phenotype of AML cell lines. The...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antibiotics, Antineoplastic
Share to Biomarkers, Tumor

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Blood Coagulation

Share to Cell Line, Tumor

Share to Daunorubicin

Share to Flow Cytometry

Share to Leukemia, Myeloid, Acute

Share to Phosphatidylserines

Source

Open in PubMed Open full text

Identifiers

PMID: 24104188
DOI: 10.1088/1478-3975/10/5/056010
PMCID: PMC3875408

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Phosphatidylserine index as a marker of the procoagulant phenotype of acute myelogenous leukemia cells.PMID 24104188Read ↗

Hypercoagulability and Tissue Factor Gene Upregulation in Hematologic MalignanciesSemantic proximity Read ↗

Prospective evaluation of the thrombotic risk in children with acute lymphoblastic leukemia carrying the MTHFR TT 677 genotype, the prothrombin G20210A variant, and further prothrombotic risk factors.Semantic proximity Read ↗

PATHOGENESIS AND TREATMENT OF THROMBOHEMORRHAGIC DIATHESIS IN ACUTE PROMYELOCYTIC LEUKEMIASemantic proximity Read ↗

The risk of thrombosis in patients with acute leukemia: occurrence of thrombosis at diagnosis and during treatment.Semantic proximity Read ↗

Characteristics of fibrinolytic disorders in acute promyelocytic leukemiaSemantic proximity Read ↗

Thrombosis in children with acute lymphoblastic leukemia Part III. Pathogenesis of thrombosis in children with acute lymphoblastic leukemia: effects of host environment.Semantic proximity Read ↗

Histones induce phosphatidylserine exposure and a procoagulant phenotype in human red blood cells.Semantic proximity Read ↗

Soluble P-selectin and Correlation with Prothrombin Fragment 1+2 in Myeloid Malignancies in Cipto Mangunkusumo General HospitalSemantic proximity Read ↗

Occurrence of thrombotic events in acute promyelocytic leukemia correlates with consistent immunophenotypic and molecular features.Semantic proximity Read ↗

Mechanisms of disease: the impact of antithrombotic therapy in cancer patients.Semantic proximity Read ↗

Relationship between clotting activity and phosphatidylserine expression on erythrocyte membranes in polycythemia vera patients with the JAK2 V617F mutation.Semantic proximity Read ↗

Reassessing the hemostatic disorder associated with acute promyelocytic leukemia [see comments]Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.